The global pharmaceutical landscape and commercial healthcare delivery networks operate within an intensely policed, hyper-regulated legal matrix. Within this institutional ecosystem, few therapeutic categories command as much multi-jurisdictional surveillance, statutory friction, and severe penal exposure as prescription opioids. Because synthetic and semi-synthetic narcotic compounds possess an extraordinary capacity to alleviate profound clinical pain alongside an […]